China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 30.97
(1.44%)
CNY 30.97
(1.44%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 355.22 Million CNY | -0.75% |
| 2022 | 532.18 Million CNY | 20.12% |
| 2021 | 443.05 Million CNY | 33.67% |
| 2020 | 331.45 Million CNY | -35.53% |
| 2019 | 514.11 Million CNY | -8.93% |
| 2018 | 564.53 Million CNY | 31.48% |
| 2017 | 429.35 Million CNY | 31.84% |
| 2016 | 325.66 Million CNY | 69.36% |
| 2015 | 192.29 Million CNY | 48.61% |
| 2014 | 129.39 Million CNY | 37.9% |
| 2013 | 93.83 Million CNY | 13.66% |
| 2012 | 82.55 Million CNY | 15.23% |
| 2011 | 71.64 Million CNY | 33.72% |
| 2010 | 53.57 Million CNY | 25.99% |
| 2009 | 42.52 Million CNY | 25.46% |
| 2008 | 33.89 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 174.74 Million CNY | 180.99% |
| 2024 Q3 | 113.73 Million CNY | -21.37% |
| 2024 Q2 | 144.65 Million CNY | -17.22% |
| 2023 Q3 | 181.36 Million CNY | -4.74% |
| 2023 Q2 | 190.39 Million CNY | -7.32% |
| 2023 Q1 | 205.42 Million CNY | 662.94% |
| 2023 FY | 528.2 Million CNY | -0.75% |
| 2023 Q4 | -215.77 Million CNY | -218.97% |
| 2022 Q4 | 26.92 Million CNY | -83.88% |
| 2022 Q1 | 124.9 Million CNY | 147.67% |
| 2022 Q2 | 213.27 Million CNY | 70.75% |
| 2022 FY | 532.18 Million CNY | 20.12% |
| 2022 Q3 | 167.06 Million CNY | -21.67% |
| 2021 Q1 | 122.97 Million CNY | 180.19% |
| 2021 Q4 | 50.43 Million CNY | -66.19% |
| 2021 Q3 | 149.19 Million CNY | 23.86% |
| 2021 Q2 | 120.45 Million CNY | -2.05% |
| 2021 FY | 443.05 Million CNY | 33.67% |
| 2020 FY | 331.45 Million CNY | -35.53% |
| 2020 Q4 | 43.88 Million CNY | -49.87% |
| 2020 Q3 | 87.55 Million CNY | 4.3% |
| 2020 Q2 | 83.94 Million CNY | -27.67% |
| 2020 Q1 | 116.06 Million CNY | -8.72% |
| 2019 Q2 | 147.36 Million CNY | 41.35% |
| 2019 Q4 | 127.14 Million CNY | -6.06% |
| 2019 Q1 | 104.25 Million CNY | -52.68% |
| 2019 FY | 514.11 Million CNY | -8.93% |
| 2019 Q3 | 135.34 Million CNY | -8.15% |
| 2018 Q2 | 143.89 Million CNY | 77.55% |
| 2018 Q4 | 220.32 Million CNY | 84.71% |
| 2018 FY | 564.53 Million CNY | 31.48% |
| 2018 Q3 | 119.27 Million CNY | -17.11% |
| 2018 Q1 | 81.04 Million CNY | -48.23% |
| 2017 FY | 429.35 Million CNY | 31.84% |
| 2017 Q2 | 108.92 Million CNY | 36.45% |
| 2017 Q3 | 84.06 Million CNY | -22.82% |
| 2017 Q1 | 79.82 Million CNY | -26.63% |
| 2017 Q4 | 156.54 Million CNY | 86.22% |
| 2016 FY | 325.66 Million CNY | 69.36% |
| 2016 Q4 | 108.79 Million CNY | 21.38% |
| 2016 Q1 | 47.01 Million CNY | -14.98% |
| 2016 Q2 | 80.21 Million CNY | 70.61% |
| 2016 Q3 | 89.63 Million CNY | 11.73% |
| 2015 Q1 | 55.92 Million CNY | 33.65% |
| 2015 Q3 | 47.03 Million CNY | 38.26% |
| 2015 Q4 | 55.3 Million CNY | 17.56% |
| 2015 Q2 | 34.02 Million CNY | -39.17% |
| 2015 FY | 192.29 Million CNY | 48.61% |
| 2014 Q2 | 28.34 Million CNY | 14.98% |
| 2014 Q1 | 24.65 Million CNY | -15.89% |
| 2014 FY | 129.39 Million CNY | 37.9% |
| 2014 Q4 | 41.84 Million CNY | 21.11% |
| 2014 Q3 | 34.55 Million CNY | 21.9% |
| 2013 Q3 | 22.12 Million CNY | -0.23% |
| 2013 Q4 | 29.3 Million CNY | 32.49% |
| 2013 FY | 93.83 Million CNY | 13.66% |
| 2013 Q1 | 20.22 Million CNY | -13.33% |
| 2013 Q2 | 22.17 Million CNY | 9.6% |
| 2012 FY | 82.55 Million CNY | 15.23% |
| 2012 Q4 | 23.34 Million CNY | 7.12% |
| 2012 Q2 | 18.34 Million CNY | -3.86% |
| 2012 Q3 | 21.79 Million CNY | 18.79% |
| 2012 Q1 | 19.07 Million CNY | 17.76% |
| 2011 Q1 | 17.33 Million CNY | 0.0% |
| 2011 FY | 71.64 Million CNY | 33.72% |
| 2011 Q2 | 18.83 Million CNY | 8.65% |
| 2011 Q3 | 19.26 Million CNY | 2.27% |
| 2011 Q4 | 16.2 Million CNY | -15.9% |
| 2010 FY | 53.57 Million CNY | 25.99% |
| 2009 FY | 42.52 Million CNY | 25.46% |
| 2008 FY | 33.89 Million CNY | 0.0% |